Dr. Mark W. Vogel, MD

Dr. Vogel practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Vogel's NPI, 1578653457, was assigned on October 13, 2006. Dr. Vogel graduated from Universidad Autonoma de Guadalajara in 1976. Dr. Vogel holds California license A33393.

Dr. Vogel's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Vogel's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Assuta Family Medical Group. Dmand AI also links Dr. Vogel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vogel practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Vogel's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Vogel is board certified in urology by the American Board of Urology. Dmand AI has Dr. Vogel's licenses on file in 2 states: California and Florida.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney stone disease, prostate inflammation or infection, transurethral procedures, urinary endoscopy and UTI among the conditions Dr. Vogel treats.

CMS data shows 1,591 Medicare services from Dr. Vogel across 19 procedure codes in 2024, for 370 Medicare patients. Medicare paid $87,805 for them.

CMS counts 370 Medicare patients who saw Dr. Vogel in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vogel's median patient age at 69, with 18% women.

In 2024, Dr. Vogel wrote 1,488 Medicare Part D claims for 289 patients. 89% of them were for generic drugs. CMS names the drug for 1,375 of them, across 17 drugs with 11 or more claims each, at $185,531 in total drug cost. In 2023, CMS named 1,302 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vogel for performance year 2024, reported individually. Dr. Vogel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vogel as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 350 general payments to Dr. Vogel from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $2,385.

Dmand AI lists 2 awards for Dr. Vogel.

Dr. Vogel graduated from Universidad Autonoma de Guadalajara in 1976. Dr. Vogel is a member of ACS, AUA and CMA.

Dr. Vogel is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.